Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alexanian

Showing results (181-190 of 196) with videos related to

Pageof 20
Sort By:
Blood|August 15, 1990
High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myelomaB Barlogie, S Jagannath, D O Dixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosineM A Dimopoulos, H Kantarjian, D Weber, et al.
Blood|November 1, 1990
Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factorsS Jagannath, B Barlogie, K Dicke, et al.
American Journal of Clinical Pathology|October 17, 2001
Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical courseA Mansoor, L J Medeiros, D M Weber, et al.
British Journal of Cancer|June 23, 2005
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cellsM Amit-Vazina, S Shishodia, D Harris, et al.
Blood|October 15, 1993
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myelomaM A Dimopoulos, R Alexanian, D Przepiorka, et al.
Radiology|December 1, 1992
Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed diseaseL A Moulopoulos, D G Varma, M A Dimopoulos, et al.
Bone Marrow Transplantation|April 1, 1990
High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myelomaG J Ventura, B Barlogie, J P Hester, et al.
Bone Marrow Transplantation|September 18, 2002
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaS Giralt, A Aleman, A Anagnostopoulos, et al.
Annals of Internal Medicine|May 1, 1982
Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patientsJ U Gutterman, S Fine, J Quesada, et al.
Pageof 20

Showing results (181-190 of 196) with videos related to

Sort By:
Pageof 20
Blood|August 15, 1990
High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myelomaB Barlogie, S Jagannath, D O Dixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosineM A Dimopoulos, H Kantarjian, D Weber, et al.
Blood|November 1, 1990
Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factorsS Jagannath, B Barlogie, K Dicke, et al.
American Journal of Clinical Pathology|October 17, 2001
Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical courseA Mansoor, L J Medeiros, D M Weber, et al.
British Journal of Cancer|June 23, 2005
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cellsM Amit-Vazina, S Shishodia, D Harris, et al.
Blood|October 15, 1993
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myelomaM A Dimopoulos, R Alexanian, D Przepiorka, et al.
Radiology|December 1, 1992
Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed diseaseL A Moulopoulos, D G Varma, M A Dimopoulos, et al.
Bone Marrow Transplantation|April 1, 1990
High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myelomaG J Ventura, B Barlogie, J P Hester, et al.
Bone Marrow Transplantation|September 18, 2002
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaS Giralt, A Aleman, A Anagnostopoulos, et al.
Annals of Internal Medicine|May 1, 1982
Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patientsJ U Gutterman, S Fine, J Quesada, et al.
Pageof 20